Jefferies Group assumed coverage on shares of China Biologic Products (NASDAQ:CBPO) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. China Biologic Products Inc (NASDAQ:CBPO) stock performance was 1.37% in last session and finished the day at $43.67. Traded volume was 59,338.00million shares in the last session and the average volume of the stock remained 23.60K shares. The beta of the stock remained 1.75. China Biologic Products Inc (NASDAQ:CBPO) insider ownership is 72.36%.

David Farr, chairman and CEO of Emerson, and Michael Neidorff, chairman, president and CEO of Centene Corp (NYSE:CNC), were named to Junior Achievement of Greater St. Louis’ Business Hall of Fame for their work with that organization. Centene Corp (NYSE:CNC) dropped -0.27 percent to $71.00 Friday on volume of 425,221.00million shares. The intra-day range of the stock was $70.87 to $72.00. Centene Corp (NYSE:CNC) has a market capitalization of $4.10billion.

LifePoint Hospitals, Inc (NASDAQ:LPNT), a leading hospital company focused on providing quality healthcare services close to home, on 20 May 2014 announced that since being selected as a Hospital Engagement Network (HEN) in December of 2011, it has demonstrated significant advancements in quality and patient safety performance at its hospitals across the country. LifePoint Hospitals, Inc. (NASDAQ:LPNT)’s stock on May 23, 2014 reported a increase of 2.19% to the closing price of $60.60. Its fifty two weeks range is $43.97 -$60.72. The total market capitalization recorded $2.70billion. The overall volume in the last trading session was 565,218.00million shares. In its share capital, LPNT has 44.48million outstanding shares.

The Pennsylvania-based company Universal Health Services, Inc. (NYSE:UHS) purchased Cedar Ridge about eight years ago, when it had already housed adult patients for several years. The company claims it was unaware until recently that it was licensed by the city to house only juvenile patients at its hospital at 6501 NE 50. On Friday, shares of Universal Health Services, Inc. (NYSE:UHS) advanced 1.35% to close the day at $89.43. Company return on investment (ROI) is 10.70% and its monthly performance is recorded as 14.48%. Universal Health Services, Inc. (NYSE:UHS) quarterly revenue growth is 7.67%.